Phase II/III blood first assay screening trial (BFAST) in patients (pts) with treatment-naive NSCLC: Initial results from the ALK plus cohortS. M. Gadgeel,T. S. K. Mok,S. Peters, J. A. A. Alexander,N. B. Leighl, V. Sriuranpong,M. Perol, Jr. De Castro G.,E. Nadal,F. De Marinis,J-Y. Han,M. Yan, T. Riehl, E. Schleifman,S. M. Paul,S. Mocci,D. Shames,M. S. Mathisen, R. DziadziuszkoAnnals of Oncology（2019）引用 43|浏览69暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
